Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$1.7 - $2.39 $26,812 - $37,695
-15,772 Reduced 48.29%
16,891 $29,000
Q2 2024

Jul 29, 2024

SELL
$1.62 - $2.04 $32,061 - $40,373
-19,791 Reduced 37.73%
32,663 $57,000
Q1 2024

Apr 29, 2024

SELL
$1.66 - $2.42 $1,701 - $2,480
-1,025 Reduced 1.92%
52,454 $99,000
Q4 2023

Feb 07, 2024

BUY
$1.25 - $2.35 $2,478 - $4,660
1,983 Added 3.85%
53,479 $115,000
Q3 2023

Nov 02, 2023

SELL
$1.5 - $3.07 $4,324 - $8,850
-2,883 Reduced 5.3%
51,496 $83,000
Q2 2023

Aug 07, 2023

BUY
$1.79 - $2.9 $13,604 - $22,040
7,600 Added 16.25%
54,379 $133,000
Q1 2023

May 09, 2023

SELL
$2.65 - $3.81 $9,195 - $13,220
-3,470 Reduced 6.91%
46,779 $138,000
Q4 2022

Feb 09, 2023

BUY
$3.38 - $4.22 $17,041 - $21,277
5,042 Added 11.15%
50,249 $183,000
Q3 2022

Nov 09, 2022

SELL
$3.43 - $5.83 $3,632 - $6,173
-1,059 Reduced 2.29%
45,207 $162,000
Q2 2022

Aug 10, 2022

SELL
$4.41 - $5.69 $17,542 - $22,634
-3,978 Reduced 7.92%
46,266 $245,000
Q1 2022

May 09, 2022

BUY
$4.81 - $6.99 $5,271 - $7,661
1,096 Added 2.23%
50,244 $276,000
Q4 2021

Feb 09, 2022

SELL
$5.97 - $7.93 $116,671 - $154,975
-19,543 Reduced 28.45%
49,148 $335,000
Q3 2021

Nov 09, 2021

BUY
$4.79 - $6.68 $14,187 - $19,786
2,962 Added 4.51%
68,691 $419,000
Q2 2021

Aug 10, 2021

SELL
$5.35 - $6.35 $37,920 - $45,008
-7,088 Reduced 9.73%
65,729 $388,000
Q1 2021

May 10, 2021

SELL
$5.68 - $7.87 $17,460 - $24,192
-3,074 Reduced 4.05%
72,817 $438,000
Q4 2020

Feb 08, 2021

BUY
$5.25 - $8.56 $98,180 - $160,080
18,701 Added 32.7%
75,891 $526,000
Q3 2020

Nov 06, 2020

SELL
$5.78 - $7.47 $17,617 - $22,768
-3,048 Reduced 5.06%
57,190 $358,000
Q2 2020

Aug 05, 2020

BUY
$4.5 - $7.02 $78,696 - $122,765
17,488 Added 40.91%
60,238 $398,000
Q1 2020

May 12, 2020

BUY
$2.87 - $5.49 $6,985 - $13,362
2,434 Added 6.04%
42,750 $199,000
Q4 2019

Feb 05, 2020

SELL
$3.84 - $4.86 $142,448 - $180,286
-37,096 Reduced 47.92%
40,316 $170,000
Q3 2019

Nov 13, 2019

BUY
$4.86 - $6.05 $27,804 - $34,612
5,721 Added 7.98%
77,412 $399,000
Q2 2019

Aug 12, 2019

SELL
$4.51 - $6.6 $48,162 - $70,481
-10,679 Reduced 12.96%
71,691 $403,000
Q1 2019

May 10, 2019

BUY
$5.16 - $6.85 $5,170 - $6,863
1,002 Added 1.23%
82,370 $513,000
Q4 2018

Feb 14, 2019

BUY
$4.89 - $7.16 $178,044 - $260,695
36,410 Added 80.99%
81,368 $413,000
Q3 2018

Nov 14, 2018

BUY
$6.89 - $7.78 $43,083 - $48,648
6,253 Added 16.16%
44,958 $324,000
Q2 2018

Aug 13, 2018

BUY
$5.19 - $7.25 $108,595 - $151,699
20,924 Added 117.68%
38,705 $0
Q1 2018

May 14, 2018

BUY
$3.56 - $5.74 $6,689 - $10,785
1,879 Added 11.82%
17,781 $97,000
Q4 2017

Feb 13, 2018

BUY
$2.76 - $3.95 $43,889 - $62,812
15,902
15,902 $54,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $280M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.